MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Neuroanatomical correlates of early cognitive change in Parkinson’s disease

E. Bunting, L-A. Leyland, R. Weil (London, United Kingdom)

Meeting: 2019 International Congress

Abstract Number: 1860

Keywords: Dementia, Magnetic resonance imaging(MRI)

Session Information

Date: Wednesday, September 25, 2019

Session Title: Neuroimaging

Session Time: 1:15pm-2:45pm

Location: Les Muses Terrace, Level 3

Objective: To identify the neuroanatomical basis of early cognitive change in Parkinson’s disease (PD).

Background: 50% of PD patients develop dementia within 10 years of diagnosis[1, 2], but the neural correlates of the earliest changes associated with cognitive decline are unclear. Previous studies have shown inconsistent atrophy patterns in PD, particularly in early disease stages [3-5]. By analysing the cortical thickness from MRI scans, we investigated whether a pattern could be detected when accounting for increased risk of dementia, as predicted by established algorithms [6, 7].

Method: 109 patients recently diagnosed with PD and 37 age and gender-matched controls without eye-disease were recruited. T1 MRI scans and neuropsychological measures were collected. Risk of cognitive involvement was calculated using two different clinical algorithms – one that combined age at onset, MMSE, education, motor score, gender and depression [6]; and another that combined age, UPSIT, RBDSQ, and depression [7]. Cortical reconstructions were performed within Freesurfer-v6.0, and cortical thickness measures between patient and control groups were compared. Correlations between cortical thickness and cognitive risk were measured using GLM (General Linear Model), and results were corrected for multiple comparisons.

Results: Bonferroni post-hoc comparisons demonstrated that patient and control groups were well matched in gender, age, education, and cognitive performance. Our results showed no differences in cortical thickness between the patient and control group, but when accounting for risk of dementia, atrophy patterns were found within the PD group. Atrophy in the precuneus, a region known to be linked with visuospatial abilities [8-10] was the most significant correlation with increased cognitive risk, which was consistent between the two different risk algorithms.

Conclusion: We identified several regions of atrophy associated with a higher risk of dementia, with the precuneus being the most significant result with both cognitive risk scores. The known involvement in visuospatial ability of this brain region provides further evidence that patients with early involvement of visual processing regions are at higher risk of dementia.

References: 1. Perez, F., et al., Risk of dementia in an elderly population of Parkinson ’ s disease patients : A 15-year population-based study. 2012. 8: p. 463-469. 2. Williams-gray, C.H., et al., The CamPaIGN study of Parkinson ’ s disease : 10-year outlook in an incident population-based cohort. 2013: p. 1258-1264. 3. Song, S.K., et al., The pattern of cortical atrophy in patients with Parkinson’s disease according to cognitive status. Mov Disord, 2011. 26(2): p. 289-96. 4. Melzer, T.R., et al., Grey matter atrophy in cognitively impaired Parkinson’s disease. J Neurol Neurosurg Psychiatry, 2012. 83(2): p. 188-94. 5. Mak, E., et al., Baseline and longitudinal grey matter changes in newly diagnosed Parkinson’s disease: ICICLE-PD study. Brain : a journal of neurology, 2015. 138(Pt 10): p. 2974-2986. 6. Liu, G., et al., Prediction of cognition in Parkinson’s disease with a clinical- genetic score: a longitudinal analysis of nine cohorts. 2018. 16: p. 620-629. 7. Schrag, A., et al., Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson’s disease: a cohort study. The Lancet. Neurology, 2017. 16(1): p. 66-75. 8. Gardini, S., et al., Visuo-Spatial Imagery Impairment in Posterior Cortical Atrophy: A Cognitive and SPECT Study %J Behavioural Neurology. 2011. 24(2). 9. Ranganath, C. and M. Ritchey, Two cortical systems for memory-guided behaviour. Nature Reviews Neuroscience, 2012. 13: p. 713. 10. Dhindsa, K., et al., Examining the role of the temporo-parietal network in memory, imagery, and viewpoint transformations. Frontiers in human neuroscience, 2014. 8: p. 709-709.

To cite this abstract in AMA style:

E. Bunting, L-A. Leyland, R. Weil. Neuroanatomical correlates of early cognitive change in Parkinson’s disease [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/neuroanatomical-correlates-of-early-cognitive-change-in-parkinsons-disease/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/neuroanatomical-correlates-of-early-cognitive-change-in-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley